Bovine/porcine Oxyntomodulin (TFA)

Send Inquiry
Bovine/porcine Oxyntomodulin (TFA)
Details
Bovine/porcine oxyntomodulin (TFA);
Category: Incretin/glucagon superfamily / feeding-regulating peptide.
Peptide Purity (HPLC) ≥95%
Counter-ion TFA
Structure 37-mer enteropancreatic peptide (bovine/porcine Oxyntomodulin)
Solubility Water, dilute acetic acid/saline
Storage Powder, −20°C, dry, light-protected
Category
Hormone Peptide
Share to
Description

Shanghai Sonyt Biotechnology Co., Ltd. is one of the leading manufacturers and suppliers of bovine/porcine oxyntomodulin (tfa) in China, also supports custom service. Welcome to wholesale bulk high quality bovine/porcine oxyntomodulin (tfa) from our factory. Contact us for more details.

 

Description A 37-mer proglucagon product acting at GLP-1 and glucagon receptors to suppress feeding, raise energy expenditure and slow gastric emptying; TFA salt.

 

Product Basic Information Table

 

Standard English Name Abbreviation/Synonym Function Tags (comma-separated) Core Structure Molecular Formula Exact Mass (Da) Average MW (Da) Salt Form Length (aa)
Oxyntomodulin (bovine, porcine), TFA salt Oxyntomodulin (bovine, porcine); OXM; Glucagon-37 (bovine, porcine); HSQGTFTSDYSKYLDSRRAQDFVQWLMNTKRNKNNIA-OH; TFA salt; PEP-OXM-01 glucagon-secretin family peptide, dual GLP-1R/GCGR agonist, intestinal L-cell peptide, Met-containing, Trp/Tyr-containing, 37-mer long peptide, TFA salt A 37-residue linear peptide of the glucagon-secretin family, produced by PC1/3 processing of proglucagon: H-His-Ser-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Lys-Tyr-Leu-Asp-Ser-Arg-Arg-Ala-Gln-Asp-Phe-Val-Gln-Trp-Leu-Met-Asn-Thr-Lys-Arg-Asn-Lys-Asn-Asn-Ile-Ala-OH (HSQGTFTSDYSKYLDSRRAQDFVQWLMNTKRNKNNIA-OH). The first 29 residues are the bovine/porcine glucagon backbone (HSQGTFTSDYSKYLDSRRAQDFVQWLMNT-OH, Gln/Q at position 3, consistent with mammalian glucagon), and the C-terminal 8-residue extension KRNKNNIA (K-R-N-K-N-N-I-A) is the characteristic oxyntomodulin tail; the bovine/porcine tail KRNKNNIA differs from the human OXM tail KRNRNNIA by a K/R substitution at position 33, so the sequence must not be mixed with the human form. The C-terminus is a free carboxylic acid (Ala-OH) and the N-terminus is a free primary amine; no intramolecular disulfide, no N-acetylation, no C-terminal amidation. Contains Met×1 (position 27), Trp×1 (25), Tyr×2 (10, 13), His×1, Arg×3, Lys×3, Asp×3, Gln×3, Ser×4, Thr×3, Asn×3, Phe×2, Leu×2, Val×1, Gly×1, Ala×2 and Ile×1; no Cys. The TFA counterion is excluded from the main-chain formula. C192H295N59O60S 4419.16 4421.87 Trifluoroacetate (TFA) salt; formula and MW are calculated on the free-peptide main chain (C192H295N59O60S, mono 4419.16 / avg 4421.87 Da). The free peptide is referenced under CAS 62340-29-8; the TFA counterion (CF3COO⁻) is excluded from the main-chain formula, and actual TFA content/stoichiometry is per lot COA. 37

 

Physicochemical Solubility & Storage Parameters

 

Product Code Appearance Long-term Storage Short-term Storage Solution Stability Solid Powder Stability
PEP-OXM-01 White to off-white powder (an amphipathic 37-mer with multiple basic Lys/Arg and acidic Asp residues and a near-neutral net charge; moderate-to-good water solubility; the TFA form is hygroscopic - reseal immediately after opening, keep in a desiccator and weigh rapidly). Store sealed, desiccated and light-protected at −20°C under argon/nitrogen; aliquot single-use portions to avoid repeated freeze-thaw. Contains Met×1 (position 27): purge with argon/nitrogen to prevent oxidation to Met(O). Contains Trp×1 and Tyr×2: keep light-protected throughout to prevent Trp/Tyr photo-oxidation. As a 37-mer it is aggregation-prone, so reconstitution and freeze-thaw should be gentle; add 0.02% Tween-20 if needed to prevent wall adsorption. The chain has no Cys/disulfide, so there is no disulfide-cleavage risk, but it should still be kept away from sulfur-containing reducing agents and oxidants. Protect the TFA salt from moisture; short-term storage at 2–8°C, dry and dark, is acceptable. Store dry and light-protected at 2–8°C; use within 2–4 weeks; store working aliquots frozen at −20°C, dark; ship sealed against moisture. Amphipathic 37-mer; soluble in water or dilute acetic acid/neutral buffer (MCE lists H2O 50 mg/mL, requiring sonication); if poorly soluble, pre-dissolve in a small volume of dilute acetic acid or DMSO before diluting with water/buffer. Prepare 1–5 mg/mL first; gentle vortexing or brief sonication may assist. After reconstitution: ≤1 week at 2–8°C; aliquot and freeze ≤3 months at −20°C; ≤3 freeze-thaw cycles; reconstitute slowly, add 0.02% Tween-20 if needed to prevent wall adsorption and aggregation; keep Met-containing solutions away from oxidants; avoid pH>8; keep solutions dark. Dry-sealed, stable for at least 2 years at 2–8°C; longer-term storage at −20°C under inert gas; keep moisture-, light- and oxidation-protected.

 

Functional Description

 

Product Code Front-end Short Summary Detailed Biological Function Research Areas (comma-separated) Targets / Receptors
PEP-OXM-01 Bovine/porcine oxyntomodulin (OXM, Glucagon-37) TFA salt, a 37-mer (HSQGTFTSDYSKYLDSRRAQDFVQWLMNTKRNKNNIA-OH); free-peptide CAS 62340-29-8; main-chain formula C192H295N59O60S, MW 4419.16/4421.87. A Met/Trp-containing intestinal L-cell peptide and dual GLP-1R/GCGR agonist that slows gastric emptying, suppresses appetite and regulates glucose and energy metabolism. Oxyntomodulin (OXM) is an intestinal peptide of the glucagon-secretin family, released post-prandially from ileocolonic L-cells by prohormone convertase PC1/3 processing of proglucagon. Cross-verification with MedChemExpress (HY-P1144, 37-mer, sequence HSQGTFTSDYSKYLDSRRAQDFVQWLMNTKRNKNNIA, formula C192H295N59O60S, MW 4421.86, free-peptide CAS 62340-29-8, synonym Glucagon-37 bovine/porcine) confirms the recalculated values mono 4419.16 / avg 4421.87 Da (within 0.05 Da). Bovine/porcine OXM is a 37-mer: the first 29 residues form the bovine/porcine glucagon backbone (Gln/Q at position 3, consistent with mammalian glucagon), and the C-terminal 8-residue extension KRNKNNIA is the characteristic OXM tail; the bovine/porcine tail KRNKNNIA differs from the human OXM tail KRNRNNIA by a K/R substitution at position 33; the C-terminus is a free acid with no disulfide. OXM is a full agonist at both the GLP-1 receptor (GLP1R) and glucagon receptor (GCGR) - class B GPCRs signaling through Gs–cAMP - with lower affinity than the native ligands GLP-1 and glucagon, but its dual agonism gives it superior body-weight lowering versus selective GLP1R agonists. Physiologically OXM slows gastric emptying, reduces gastric acid secretion, acts on the hypothalamic arcuate nucleus to suppress appetite/food intake, stimulates insulin release and increases energy expenditure, making it a key tool peptide in obesity and type-2-diabetes metabolism research. Applications include dual/multi-agonist (GCG/GLP-1/GIP) drug design, intestinal L-cell secretion, gastric-emptying and appetite regulation, glucose and energy metabolism, and weight-loss mechanism models. Formula and MW are calculated on the free-peptide main chain without counterions; this product is the TFA salt, with salt form per COA. incretin and metabolic-disease research, GLP-1R/GCGR dual-agonist drug design, gastric emptying and appetite regulation, obesity/weight loss and energy metabolism, type-2-diabetes glucose control, peptide medicinal chemistry Dual agonist at the GLP-1 receptor GLP1R (class B GPCR, Gs–cAMP) and glucagon receptor GCGR (class B GPCR, Gs–cAMP); hypothalamic appetite-regulating pathways; pancreatic insulin-secretion regulation

 

 

 

 

Hot Tags: bovine/porcine oxyntomodulin (tfa), China bovine/porcine oxyntomodulin (tfa) manufacturers, suppliers, factory, 76461-17-1, Bradykinin 1 3 , CAS 161748 29 4, CAS 25696 21 3, GLP 1 9 36 amide, hormone peptide

Send Inquiry